2[1]Ferro JM,Canhao P,Stam J,et al.Prognosis of cerebral vein and dural sinus thrombosis:results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)[J].Stroke,2004,35:664-670.
4[4]Bousser MG.Cerebral venous thrombosis:diagnosis and management[J].J Neurol,2000,247:252-258.
5[5]Martinelli I,Battaglioli T,Pedotti P,et al.Hyperhomocysteinemia in cerebral vein thrombosis[J].Blood,2003,102:1363-1366.
6[6]Cantu C,Alonso E,Jara A,et al.Hyperhomocysteinemia,low folate and vitamin B12 concentrations,and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis[J].Stroke,2004,35:1790-1794.
7[7]Lichy C,Dong-Si T,Reuner K,et al.Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems[J].J Neurol,2006,253:316-320.
8[8]Cumurciuc R,Crassard I,Sarov M,et al.Headache as the only neurological sign of cerebral venous thrombosis:a series of 17 cases[J].J Neurol Neurosurg Psychiatry,2005,76:1084-1087.
9[9]Masuhr F,Mehraein S,Einh(a)iupl K.Cerebral venous and sinus thrombosis[J].J Neurol,2004,251:11-23.
10[10]Selim M,Fink J,Linfante I,et al.Diagnosis of cerebral venous thrombosis with echo-planar T2*SW-weighted magnetic resonance imaging[J].Arch Neurol,2002,59:1021-1026.
